Literature DB >> 23263168

Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database.

Debraj Mukherjee1, Kaisorn L Chaichana, Scott L Parker, Ziya L Gokaslan, Matthew J McGirt.   

Abstract

OBJECTIVE: Malignant osseous spinal neoplasms are aggressive tumors associated with poor outcomes despite aggressive multidisciplinary measures. While surgical resection has been shown to improve short-term local disease control, it remains debated whether surgical resection is associated with improved overall survival in patients with malignant primary osseous spinal neoplasms. The aim of this manuscript is to review survival data from a US cancer registry spanning 30 years to determine if surgical resection was independently associated with overall survival.
METHODS: The SEER registry (1973-2003) was queried to identify cases of histologically confirmed primary spinal chordoma, chondrosarcoma, osteosarcoma, or Ewing's sarcoma of the mobile spine and pelvis. Patients with systemic metastasis were excluded. Age, gender, race, tumor location, and primary treatments were identified. Extent of local tumor invasion was classified as confined within periosteum versus extension beyond periosteum to surrounding tissues. The association of surgical resection with overall survival was assessed via Cox analysis adjusting for age, radiotherapy, and tumor invasiveness.
RESULTS: 827 patients were identified with non-metastatic primary osseous spinal neoplasms (215 chordoma, 282 chondrosarcoma, 158 osteosarcoma, 172 Ewing's sarcoma). Overall, median survival was histology specific (chordoma, 96 months; Ewing's sarcoma, 90 months; chondrosarcoma, 88 months; osteosarcoma, 18 months). Adjusting for age, radiation therapy, and extent of local tumor invasion in patients with isolated (non-metastatic) spine tumors, surgical resection was independently associated with significantly improved survival for chordoma [hazard ratio (95 % confidence interval; 0.617 (0.25-0.98)], chondrosarcoma [HR (95 %CI); 0.153 (0.07-0.36)], osteosarcoma [HR (95 %CI); 0.382 (0.21-0.69)], and Ewing's sarcoma [HR (95 %CI); 0.494 (0.26-0.96)].
CONCLUSION: In our analysis of a 30-year US population-based cancer registry (SEER), patients undergoing surgical resection of primary spinal chordoma, chondrosarcoma, Ewing's sarcoma, or osteosarcoma demonstrated prolonged overall survival independent of patient age, extent of local invasion, or location. Surgical resection may play a role in prolonging survival in the multi-modality treatment of patients with these malignant primary osseous spinal neoplasms.

Entities:  

Mesh:

Year:  2012        PMID: 23263168      PMCID: PMC3676564          DOI: 10.1007/s00586-012-2621-4

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  37 in total

1.  Total en bloc lumbar spondylectomy. Case report.

Authors:  E Marmor; L D Rhines; J S Weinberg; Z L Gokaslan
Journal:  J Neurosurg       Date:  2001-10       Impact factor: 5.115

Review 2.  Current concepts in the treatment of Ewing's sarcoma.

Authors:  Kristy L Weber
Journal:  Expert Rev Anticancer Ther       Date:  2002-12       Impact factor: 4.512

3.  An epidemiological study of osteogenic sarcoma in Kenya: the variations in incidence between ethnic groups and geographic regions, 1968-1978.

Authors:  E G Bovill; A Kung'u; A Bencivenga; M K Jeshrani; B S Mbindyo; P M Heda
Journal:  Int Orthop       Date:  1985       Impact factor: 3.075

4.  The incidence of malignant primary bone tumours in relation to age, sex and site. A study of osteogenic sarcoma, chondrosarcoma and Ewing's sarcoma diagnosed in Sweden from 1958 to 1968.

Authors:  S E Larsson; R Lorentzon
Journal:  J Bone Joint Surg Br       Date:  1974-08

5.  Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.

Authors:  R G Evans; M E Nesbit; E A Gehan; L A Garnsey; O Burgert; T J Vietti; A Cangir; M Tefft; P Thomas; F B Askin
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

6.  Primary malignant tumors of bone: incidence in Ibadan, Nigeria.

Authors:  G A Oyemade; A A Abioye
Journal:  J Natl Med Assoc       Date:  1982-01       Impact factor: 1.798

7.  Chondrosarcoma of the spine.

Authors:  T C Shives; R A McLeod; K K Unni; M F Schray
Journal:  J Bone Joint Surg Am       Date:  1989-09       Impact factor: 5.284

8.  Combined treatment of osteosarcoma of the spine.

Authors:  N Sundaresan; G Rosen; A G Huvos; G Krol
Journal:  Neurosurgery       Date:  1988-12       Impact factor: 4.654

9.  Osteosarcoma of the spine.

Authors:  T C Shives; D C Dahlin; F H Sim; D J Pritchard; J D Earle
Journal:  J Bone Joint Surg Am       Date:  1986-06       Impact factor: 5.284

10.  Incidence of bone sarcoma in SW England, 1946-74, in relation to age, sex, tumour site and histology.

Authors:  C H Price; G M Jeffree
Journal:  Br J Cancer       Date:  1977-10       Impact factor: 7.640

View more
  22 in total

Review 1.  Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour.

Authors:  Raphaële Charest-Morin; Nicolas Dea; Charles G Fisher
Journal:  Curr Treat Options Oncol       Date:  2016-02

Review 2.  Diffuse skeletal muscle metastases from sacral chordoma.

Authors:  Kathleen Carey; Joseph Bestic; Steven Attia; Cherise Cortese; Manoj Jain
Journal:  Skeletal Radiol       Date:  2014-01-10       Impact factor: 2.199

Review 3.  Surgical treatment of sarcomas of the spine.

Authors:  Ali K Ozturk; Ziya L Gokaslan; Jean-Paul Wolinsky
Journal:  Curr Treat Options Oncol       Date:  2014-09

4.  Expert's Comment concerning Grand Rounds case entitled "Cryosurgery in the excision of a giant local recurrent sacral chordoma: a case report and literature review" by V. Pipola et al. (Eur Spine J; https://doi.org/10.1007/s00586-017-5438-3).

Authors:  Sanjay Konakondla; Ziya L Gokaslan
Journal:  Eur Spine J       Date:  2018-11-02       Impact factor: 3.134

5.  Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.

Authors:  Armin Arshi; Justin Sharim; Don Y Park; Howard Y Park; Hamed Yazdanshenas; Nicholas M Bernthal; Arya N Shamie
Journal:  Spine J       Date:  2016-11-14       Impact factor: 4.166

6.  Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study.

Authors:  Kehan Song; Xiao Shi; Xin Liang; Hongli Wang; Fei Zou; Feizhou Lu; Xiaosheng Ma; Jianyuan Jiang
Journal:  Int Orthop       Date:  2018-04-21       Impact factor: 3.075

7.  Risk factors and long-term survival in adult patients with primary malignant spinal cord astrocytomas.

Authors:  Albert P Wong; Nader S Dahdaleh; Richard G Fessler; Stephanie C Melkonian; Yimo Lin; Zachary A Smith; Sandi K Lam
Journal:  J Neurooncol       Date:  2013-09-29       Impact factor: 4.130

8.  Surgical and Functional Outcomes of En Bloc Resection of Sacral Chordoma: a Retrospective Analysis.

Authors:  Rohit Sharma; Debashish Mukherjee; Amiy Arnav; R Shankaran; Varun Kumar Agarwal
Journal:  Indian J Surg Oncol       Date:  2021-11-19

Review 9.  Systematic Review of En Bloc Resection in the Management of Ewing's Sarcoma of the Mobile Spine with Respect to Local Control and Disease-Free Survival.

Authors:  Mathew David Sewell; Kimberly-Anne Tan; Nasir A Quraishi; Corina Preda; Peter P Varga; Richard Williams
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

10.  C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study.

Authors:  Gerhard Martin Hobusch; Florian Bodner; Sonja Walzer; Rodrig Marculescu; Philipp T Funovics; Irene Sulzbacher; Reinhard Windhager; Joannis Panotopoulos
Journal:  World J Surg Oncol       Date:  2016-04-18       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.